- Home
- AMTD vs COEP Comparison
AMTD vs COEP Comparison
Compare AMTD & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMTD | COEP |
|---|---|---|
| Founded | 2003 | 2017 |
| Country | France | United States |
| Employees | N/A | 7 |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.2M | 72.7M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMTD | COEP |
|---|---|---|
| Price | $1.00 | $11.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.6K | ★ 36.6K |
| Earning Date | 12-30-2025 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.31 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.87 | $6.32 |
| 52 Week High | $1.65 | $21.41 |
Technical Indicators
Market Signals| Indicator | AMTD | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 48.38 | 43.94 |
| Support Level | $1.00 | $10.98 |
| Resistance Level | $1.08 | $13.23 |
| Average True Range (ATR) | 0.04 | 0.97 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 38.46 | 44.24 |
Price Performance
Historical ComparisonAbout AMTD AMTD IDEA Group each representing six (6)
AMTD IDEA Group is a financial institution operating in five business segments: The capital market solutions segment assists customers in raising funds through equity and debt financing, private placements, and debt issuances. The digital solutions and other services segment provides institutional and corporate clients with paid access to enhance investor communication and relations, corporate communication also provides digital financial solution services. The Media and entertainment segment offers print and digital advertising campaigns, licensing, and marketing services including branded content, video production. The hotel operations, hospitality, and VIP services segment engages in hotel investments, hotel operations, hospitality, and VIP services; and Strategic investment segment.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.